Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV001170247 | SCV001332807 | likely benign | Cardiomyopathy | 2018-07-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001490888 | SCV001695462 | likely benign | Hypertrophic cardiomyopathy 14 | 2024-07-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002365821 | SCV002662225 | likely benign | Cardiovascular phenotype | 2019-11-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |